Optimizing Control of Anemia With Ferric Carboxymaltose Administration in Peritoneal Dialysis

Journal of Clinical Nephrology and Renal Care
doi 10.23937/2572-3286.1510044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ClinMed International Library

Related search

Treatment of Iron Deficiency and Iron Deficiency Anemia With Intravenous Ferric Carboxymaltose in Pregnancy

Archives of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2018English

Safety and Efficacy of Ferric Carboxymaltose in Children and Adolescents With Iron Deficiency Anemia

Journal of Pediatrics
Child HealthPediatricsPerinatology
2017English

Anaphylaxis to Intravenous Ferric Carboxymaltose

Journal of the Korean Neurological Association
2018English

Hookworm Anemia in a Peritoneal Dialysis Patient in China

Korean Journal of Parasitology
ParasitologyInfectious Diseases
2016English

Intravenous Ferric Carboxymaltose for Anaemia in Pregnancy

BMC Pregnancy and Childbirth
GynecologyObstetrics
2014English

Intravenous Ferric Carboxymaltose for Heart Failure With Iron Deficiency

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Is an Additional Dose of Intravenous Ferric Carboxymaltose Useful in the Treatment of Iron Deficiency Anemia?

International Journal of Blood Research and Disorders
2019English

A Comment on the Comparative Safety of Intravenous Ferumoxytol Versus Ferric Carboxymaltose in Iron Deficiency Anemia

American Journal of Hematology
Hematology
2018English

Beneficial Effect of High Dose Darbepoetin-Alfa in Peritoneal Dialysis Patients With Renal Anemia

Nihon Toseki Igakkai Zasshi
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy